Vaccinot

It’s been a long time since I’ve read my virology and epidemiology textbooks and I am certainly no expert, but if the drug companies can be convinced to keep working on a SARS-CoV-2 vaccine, the chances we can develop one is about 95% from what I can tell.

If we do fail to develop one, the most likely reason for that is not that it’s technologically impossible but that it’s not profitable.